Search

everythinglearnresearchcommunity

for

Search:↓

New compounds were found to help increase hair growth and decrease hair loss.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

In 2019, dermatology and venereology improved skin cancer imaging, advanced in treating skin conditions like psoriasis, and explored the skin microbiome's role in diseases.

Healthy aging can be promoted through physical activity, lifestyle changes, and certain treatments.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Chronic granulomatous disease may be linked to developing systemic lupus erythematosus.

Stem cell therapy shows promise for treating hair loss in androgenetic alopecia.

The document tests knowledge and decision-making in hematology through multiple-choice questions.

New resveratrol-related compounds show promise for treating various health issues but need more research for clinical use.

Fat stem cells from diabetic mice can still help heal wounds.

The meeting highlighted the importance of genetic testing and multidisciplinary approaches in pediatric dermatology.

The conclusion is that certain genetic factors and blood types may affect COVID-19 severity, but changes in ACE2 and TMPRSS2 genes are not clearly linked to it.

There are many treatments for common hair loss, but more trials are needed to decide which are best.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

JAK inhibitors effectively regrow hair in alopecia areata but hair loss often returns after stopping treatment.

No method fully prevents hair loss from chemotherapy, but some methods can reduce it and improve quality of life.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

Tildrakizumab may cause alopecia areata, but stopping it and using corticosteroids can regrow hair.

Blocking COX, especially COX-2, in the skin can reduce inflammation and pain and may help prevent skin cancer.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Guselkumab effectively treats skin reactions caused by adalimumab in certain conditions.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Vitamin D and its receptor regulate skin functions like cell growth, immunity, hair cycle, and tumor prevention.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

Hair follicle cells can become bone-like cells, useful for bone repair.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Bazhengsan reduces inflammation and tissue growth in chronic prostatitis.

Retinol may affect immune responses in people with frequent skin boils.